Skip to content

NED PHARMA

Active Private limited companyfounded 2025active for 1 yearChaussée de Maubeuge 274, 7022 MonsKBO/BCE: BE 1020.230.261

Board

1 director, since incorporation
Director (not named in the articles)
appointed by deed of 24-02-2025 term without a fixed end

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
NDONGO ETOGO Désiré François
Director (not named in the articles)
Board
Mandates as a list
  • NDONGO ETOGO Désiré François
    • Director (not named in the articles), appointed by deed of 24-02-2025, still in office

Control

This company
NED PHARMA
Equity €23,080
Profit €20,080 in 2025

Capital

Contribution
€3,000
Shares
3,000
Contribution per share
€1
Equity per share
€7.69 in 2025
Source
deed of 24-02-2025

Articles of association

deed of 24-02-2025 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant,moitié acquéreurs au prorata si plusieurs, nullité”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Wednesday of June
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

At incorporation deed of 24-02-2025 ↗

Next steps